Impact Therapeutics announces completion of series D1 financing
China | News | 0 Comment | 14 Mar, 2022
IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer ther...Read more
Hexvix obtained CDE approval for the inclusion in the clinical real-world evidence pilot study
China | News | 0 Comment | 14 Mar, 2022
Asieris Pharmaceuticals, a global innovative biopharma company specializing in discovering and developing innovativ...Read more
Pulnovo Medical appoints Jessie Lian Jia as New CEO
China | News | 0 Comment | 11 Mar, 2022
Pulnovo Medical Limited, a globally recognized OTM innovative platform, recently announced the appointment of Jessie Lia...Read more
China's Gan & Lee Pharma begins first-in-human trial for diabetes drug
China | News | 0 Comment | 11 Mar, 2022
Chinese firm Gan & Lee Pharmaceuticals has announced that the first subject has been dosed in our Phase I, double-bl...Read more
Hong Kong-based Insilico Medicine focuses on discovery of potential therapeutics for Cystinosis
China | News | 0 Comment | 10 Mar, 2022
The MIKADO group, a translational team at the University of Zurich (UZH) focused on generating evidence-driven...Read more
Hong Kong study finds that smoking increases risk of COVID-19
China | News | 0 Comment | 09 Mar, 2022
Researchers from the School of Public Health, LKS Faculty of Medicine of The University of Hong Kong (HKUMed), in collab...Read more
China's SeekIn gets CE Mark approval for SeekInCare Pan Cancer early detection test
China | News | 0 Comment | 08 Mar, 2022
SeekIn Inc, the leader in blood-based cancer early detection and monitoring technology, has announced the CE (Conformit&...Read more
China approves phase II trial of Akeso's cancer drug
China | News | 0 Comment | 08 Mar, 2022
Akeso, Inc., a biopharmaceutical company dedicated to the development of innovative antibody drugs, has announced that t...Read more
WuXi ATU announces launch of TESSA Technology
China | News | 0 Comment | 08 Mar, 2022
WuXi Advanced Therapies (WuXi ATU), a wholly owned subsidiary of WuXi AppTec, announced the launch of Tetracycline-Enabl...Read more
Singleron extends reach outside China, strengthens expertise in translational & clinical research
China | News | 0 Comment | 08 Mar, 2022
Singleron Biotechnologies, a leading Chinese genomics company that develops groundbreaking single-cell multi-omics platf...Read more
AnchorDx appoints Dr. Marina Bibikova as Chief Scientific Officer
China | News | 0 Comment | 07 Mar, 2022
AnchorDx, a world-leading developer of cancer screening and early detection solutions, is delighted to announc...Read more
111, Inc & Beilin Pharma lay focus on digital marketing of Chinese patent medicines
China | News | 0 Comment | 07 Mar, 2022
111, Inc., a leading tech-enabled healthcare platform company in China, has signed a strategic cooperation agreement on ...Read more
I-Mab receives FDA orphan drug designation for cancer drug
China | News | 0 Comment | 04 Mar, 2022
China based I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercializa...Read more
China-based startup InxMed raises $50 M in Series B Financing
China | News | 0 Comment | 04 Mar, 2022
InxMed Co., Ltd, a clinical-stage biotechnology startup based in China, has announced that it had completed $5...Read more
Overland Pharmaceuticals Appoints Dr. Xun Liu as Chief Technology Officer
China | News | 0 Comment | 03 Mar, 2022
Overland Pharmaceuticals, a premier biopharmaceutical company bringing innovative medicines to patients in Asia and worl...Read more
China's Adagene partners with French firm Sanofi for Immuno-Oncology
China | News | 0 Comment | 03 Mar, 2022
China's Adagene, a company transforming the discovery and development of antibody-based therapies, has announced a...Read more
China approves Phase II clinical trial of InnoCare's cancer drug
China | News | 0 Comment | 03 Mar, 2022
InnoCare Pharma, a leading biopharmaceutical company, has announced the Investigational New Drug (IND) approval of its B...Read more
IASO Bio strengthens manufacturing of CAR-T cell therapy products in China
China | News | 0 Comment | 02 Mar, 2022
IASO Biotherapeutics, a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing i...Read more